setiptiline has been researched along with Depressive Disorder in 3 studies
setiptiline: structure given in UD 37:228j
setiptiline : A tetracyclic antidepressant that is 2,3,4,9-tetrahydro-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine carrying a methyl group at position 2. Its maleate salt is used for the treatment of depression in Japan.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Setiptiline maleate (SPT) was administered orally to 45 subjects aged 22-86 years and steady state plasma levels were determined by mass fragment chromatography (GC-MF) to examine the effect of aging on those values." | 5.07 | The effect of age on plasma level of setiptiline maleate in depressed patients. ( Aoba, A; Chishima, T; Kamimura, M; Morokawa, Y; Negishi, K; Sakai, T; Takagi, H; Takeshita, T; Tsuneizumi, T; Yamaguchi, N, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamimura, M | 1 |
| Aoba, A | 1 |
| Yamaguchi, N | 1 |
| Tsuneizumi, T | 1 |
| Takagi, H | 1 |
| Chishima, T | 1 |
| Sakai, T | 1 |
| Negishi, K | 1 |
| Morokawa, Y | 1 |
| Takeshita, T | 1 |
| Sato, T | 1 |
| Sakado, K | 1 |
| Sato, S | 1 |
| Nisijima, K | 1 |
| Oyafuso, K | 1 |
| Shimada, T | 1 |
| Hosino, H | 1 |
| Ishiguro, T | 1 |
1 trial available for setiptiline and Depressive Disorder
| Article | Year |
|---|---|
The effect of age on plasma level of setiptiline maleate in depressed patients.
Topics: Adult; Aged; Aged, 80 and over; Aging; Antidepressive Agents; Depressive Disorder; Female; Gas Chrom | 1994 |
2 other studies available for setiptiline and Depressive Disorder
| Article | Year |
|---|---|
Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression?
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Depressive Disorder; Dose- | 1993 |
Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy.
Topics: Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Electroconvulsive Therapy; Female; | 1996 |